LULU Settles With Wilson, HIMS and CHWY Value Picks
Rendy Andriyanto
Gotrade Team
Reviewed by Gotrade Internal Analyst
Share this article
Gotrade News - Lululemon settled a long-running dispute with founder Chip Wilson, closing a major governance overhang. The athleisure retailer traded at $132.09 on May 28, up 0.69 percent ahead of June 4 earnings.
The settlement frees management to focus on core operations as the stock sits near a 52-week low. Investors are also weighing Hims & Hers and Chewy as undervalued consumer and healthcare ideas this week.
Key Takeaways
Lululemon settled with Chip Wilson, removing a governance overhang before its June 4 earnings report.
Hims & Hers trades near $27.77 after a 6.2 percent rally, with telehealth disruption as the bull thesis.
Chewy at $22.28 reflects a 25 to 40 percent 2026 drawdown despite 24 percent free cash flow growth in 2025.
According to The Motley Fool, Lululemon (LULU) reached terms with its founder after months of public friction. The agreement removes a distraction that had weighed on the shares through a 52-week low earlier this cycle.
Analyst Parkev Tatevosian noted the management team now has more time to focus on core operations. The June 4 earnings report becomes the next catalyst for the athleisure brand under turnaround scrutiny against Nike.
Per the same publisher, Hims & Hers Health (HIMS) closed at $27.77 on May 28, rising 6.2 percent on the session. Tatevosian described the stock as one of the most volatile names in the market right now.
As reported by The Motley Fool, the bull case rests on healthcare disruption through telehealth and direct-to-consumer prescriptions. Recent earnings sparked a drawdown that left bulls and bears debating whether dips are entry points or warnings.
The volatility profile reflects how subscriber growth and category expansion drive sentiment more than quarterly margins. Investors tracking HIMS must weigh execution risk against the broader telehealth tailwind in 2026.
According to The Motley Fool, Chewy (CHWY) traded at $22.28 on May 28, sitting 25 to 40 percent below its 2026 peak. The online pet retailer has lagged broader consumer benchmarks through the first half of the year.
Free cash flow grew 24 percent in 2025, suggesting the business model is converting orders into cash more efficiently. Tatevosian framed the e-commerce shift and Autoship recurring revenue as the foundation of the undervalued call.
The bear flag remains consumer-discretionary pressure and a slowing growth narrative across pet retail. Bulls counter that the cash generation profile already prices in a worst-case macro outcome.
Recurring Autoship orders provide visibility on revenue even when discretionary spend across the broader consumer complex softens. That structural feature supports the undervalued framing despite the steep year-to-date price decline.
Taken together, the three names span apparel, healthcare, and pet retail across the American consumer complex. Each carries a distinct catalyst path that investors can size based on risk appetite and time horizon for the coming quarters.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.
